Abbott glucose meter patent suit
This article was originally published in The Gray Sheet
Executive Summary
San Francisco federal jury rules Aug. 8 that Abbott patent '890 related to blood glucose monitors and test strips is invalid. Abbott had asserted in 2004 that Becton Dickinson and Nova Biomedical, which manufactured certain BD products including the BD Logic monitor, infringed four of its patents. The latest ruling relieves BD/Nova from the last of the four claims. A judge ruled in April that two of the other patents had not been infringed and one was invalid. Abbott had sought $42 million in damages. BD exited the glucose monitoring market in 2006 (1"The Gray Sheet" Oct. 2, 2006, p. 13)
You may also be interested in...
BD Exits Glucose Monitoring Market After Being “Eclipsed” By Competitors
Becton Dickinson is dropping out of the increasingly competitive blood glucose monitoring market, acknowledging that it has been too slow to innovate in a sector that generated about $105 mil. in BD sales for the 12 months ended Sept. 30
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.